The quantum landscape in biopharma is rapidly changing. While quantum computing continues to evolve, investments are growing in the companies focused on modelling quantum-based applications. In the next edition of the Convergence Quantum Salon series, a curated group of biopharma executives, applied quantum founders and quantum computing developers will share in a discussion led by investors for their perspective on the most promising areas of growth, opportunity and impact. Thanks to our sponsor, DLA Piper, and MassBio for hosting this event.

Registration is by invitation only and subject to approval of the program hosts. If you have received an invitation, you will receive a calendar invitation as confirmation. Space is limited and subject to availability.